Core Scientific Reports Warrant Exercises

TL;DR

Core Scientific's warrants exercised, watch for cash influx!

AI Summary

Core Scientific, Inc. filed an 8-K on April 15, 2024, to report on the exercise of warrants. Specifically, the company announced that warrants with an exercise price of $6.81 per share and warrants with an exercise price of $0.01 per share were exercised on April 15, 2024. This filing also includes financial statements and exhibits.

Why It Matters

The exercise of warrants can indicate investor confidence and potentially increase the company's cash reserves, impacting its financial structure.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of warrant exercises and does not indicate new or significant risks.

Key Numbers

• $6.81 — Warrant Exercise Price (Price per share for exercised warrants.)
• $0.01 — Warrant Exercise Price (Price per share for exercised warrants.)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• April 15, 2024 (date) — Date of Report
• $6.81 (dollar_amount) — Warrant Exercise Price
• $0.01 (dollar_amount) — Warrant Exercise Price
• Power & Digital Infrastructure Acquisition Corp. (company) — Former Company Name

FAQ

Key Financial Figures

• $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20240415.htm (8-K) — 36KB
• exhibit991-pressrelease.htm (EX-99.1) — 13KB
• image1a.jpg (GRAPHIC) — 2KB
• image_2.jpg (GRAPHIC) — 42KB
• imagea.jpg (GRAPHIC) — 3KB
• 0001628280-24-016137.txt ( ) — 297KB
• core-20240415.xsd (EX-101.SCH) — 3KB
• core-20240415_def.xml (EX-101.DEF) — 17KB
• core-20240415_lab.xml (EX-101.LAB) — 30KB
• core-20240415_pre.xml (EX-101.PRE) — 17KB
• core-20240415_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On April 12, 2024, the Company issued a press release announcing it has filed a Registration Statement on Form S-1 strictly to register the offer and sale of outstanding common stock on behalf of certain existing stockholders to satisfy registration rights that were granted to such stockholders. The Company is not selling any shares of common stock being offered by the registration statement and will not receive any of the proceeds from any sale of such shares by any selling stockholders. The registration statement has been filed with the SEC but is not yet effective. The securities registered under the registration statement may not be sold, nor may offers to buy be accepted prior to the time the registration statement is declared effective. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. A copy of the prospectus relating to the offering, when available, may be obtained from the Company at ir.corescientific.com. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release dated April 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: April 15, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR